April 11th, 2016
•An integrated system for targeted next-generation sequencing of oncology specimens is described. This cross-platform system is optimized for low-quality and low-quantity tumor biopsies, accommodates low DNA inputs, includes well-characterized multi-variant controls, and features a novel variant caller that is informed by quantitative pre-analytical quality control measures.
Tags
Related Videos
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Collection and Extraction of Saliva DNA for Next Generation Sequencing
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Manufacture of a Multi-Purpose Low-Cost Animal Bench-Model for Teaching Tracheostomy
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved